Nov 07, 2017
GSK Presents New Data at ACR for BENLYSTA (belimumab) for Subcutaneous Use (SC), Showing Reduced Need to Increase Corticosteroid Dose
Nov 07, 2017
New Survey Finds More Than Two Thirds of Adults May be Missing Out on Vaccinations
Nov 06, 2017
New GSK Multi-country Survey Reveals Need for Improved Awareness Around Long-term Impact and Appropriate use of Corticosteroids in SLE Management
Oct 25, 2017
CDC's Advisory Committee on Immunization Practices recommends Shingrix as the preferred vaccine for the prevention of shingles for adults aged 50 and up
Oct 20, 2017
Shingrix approved in the US for prevention of shingles in adults aged 50 and over
Sep 21, 2017
Avara Pharmaceutical Services acquires Consumer Healthcare facility from GSK in Aiken, South Carolina
Sep 13, 2017
FDA Advisory Committee votes unanimously for Shingrix (HZ/su) in the US for prevention of herpes zoster (shingles) in adults ages 50 and over
Aug 31, 2017
GlaxoSmithKline Japan Selects SciBite Semantic Platform to Enhance Pharmacovigilance Capabilities
Jul 21, 2017
GSK receives FDA approval for a new self-injectable formulation of Benlysta (belimumab) for systemic lupus erythematosus
Jul 14, 2017
GSK ships 2017-18 seasonal influenza vaccines for US market
Jun 28, 2017
Schneider Electric Partners with GSK to Help Suppliers Reduce Carbon Emissions
Jun 21, 2017
GSK presents positive results from Phase III revaccination study of its candidate shingles vaccine Shingrix at CDC's Advisory Meeting